Combating COVID-19 with mesenchymal stem cell therapy K Rajarshi, A Chatterjee, S Ray Biotechnology reports 26, e00467, 2020 | 101 | 2020 |
Nucleic acid-based therapy for coronavirus disease 2019 R Piyush, K Rajarshi, A Chatterjee, R Khan, S Ray Heliyon 6 (9), 2020 | 40 | 2020 |
Recent trends in analytical and digital techniques for the detection of the SARS-Cov-2 CD Mukhopadhyay, P Sharma, K Sinha, K Rajarshi Biophysical chemistry 270, 106538, 2021 | 37 | 2021 |
Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19 K Rajarshi, R Khan, MK Singh, T Ranjan, S Ray, S Ray Gene 768, 145313, 2021 | 32 | 2021 |
BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope? K Rajarshi, A Chatterjee, S Ray Medicine in Drug Discovery 7, 100049, 2020 | 30* | 2020 |
Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy R Piyush, K Rajarshi, R Khan, S Ray Open Biology 10 (9), 200174, 2020 | 22 | 2020 |
Molecular chaperones in protein folding and stress management in cyanobacteria A Chatterjee, K Rajarshi, H Ghosh, MK Singh, OP Roy, S Ray Advances in cyanobacterial biology, 119-128, 2020 | 11 | 2020 |
Polyphenol MHQP as an allosteric inhibitor of Kinesin-5: Cease the molecular catwalk of “Drunken Sailor” M Shukla, S Maji, K Rajarshi, S Bhattacharyya Indian Journal of Biochemistry and Biophysics (IJBB) 60 (9), 703-709, 2023 | 1 | 2023 |
Extremophiles for Wastewater Treatment K Rajarshi, K Sudharshana, S Roy Extremophiles, 23-42, 2023 | 1 | 2023 |
An Intimate Alliance of DNA-Damage Response Network with Cell-Cycle Checkpoints Amid Events of Uncontrolled Cellular Proliferation: A Mini-Review A Chatterjee, K Rajarshi, R Khan, H Ghosh, S Kapoor, S Ray Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | | 2021 |
Development of Human Milk Fat Analogues: A review on Techniques and Accomplishments K Rajarshi Preprints, 2020 | | 2020 |